Select a community
HIV
Find out more about the PatientsLikeMe
HIV Community
Home > Community Treatment Reports > Raltegravir Treatment Report
What is Raltegravir?

Raltegravir is an HIV integrase transfer inhibitor (HIV-1 INSTI). It is used in combination with other antiretroviral agents to treat HIV-1 infection in treatment experienced patients with evidence of viral replication and resistance to multiple antiretroviral agents.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Treat my HIV 49 4
2XDAILY 3 0
Treat my HIV 2 0
Other 1 1

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
0 0%
None
5 100%

Dosages

Top 10 dosages based on patients currently taking Raltegravir. See all 12 dosages

  daily 1 mg daily 1 other daily 2 mg daily 2 other daily 400 mg weekly 200 mg daily 300 mg daily 400 mcg daily 400 mg daily 800 mg daily 1200 mg daily
  2 Number of Patients: 2 1 Number of Patients: 1 2 Number of Patients: 2 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 16 Number of Patients: 16 41 Number of Patients: 41 2 Number of Patients: 2  

Stop Reasons

Why Patients Stopped Taking Raltegravir (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice
1 50% Doctor's advice: 50%
Side effects too severe
1 50% Side effects too severe: 50%
Not indicated
1 50% Not indicated: 50%

See all 2 patients who’ve stopped taking Raltegravir

Currently Taking Raltegravir

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
3
10
12
10
5

Stopped Taking Raltegravir

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
2
0
0
0
0
0

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
5 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
1 20%
Not at all
4 80%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
1 20%
< $25
3 60%

Report created on November 22, 2009.